CHINESE ACADEMY OF SCIENCES;GUANGZHOU INSTITUTE OF BIOMEDICINE AND HEALTH
发明人:
DING, KE,WONG, CHIWAI,KANG, ZHANFANG,ZHOU, XI
申请号：
CA2750859
公开号：
CA2750859C
申请日:
2009.03.05
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The compounds according to formula VIII, their pharmaceutically acceptableacid or base addition salts,and the uses thereof is disclosed. These compounds and their pharmaceuticallyacceptable acid or baseaddition salts can be used for the preparing a medicament for modulatingestrogen related receptor (ERR),and treating metabolic diseases, such as high blood fat, fatty liver,hyperglycemia, diabetes, obesity, etc. Thedefinition of the groups of the formula is defined as the description.(see formula VIII)
